*By Britt Terrell* Tesla is bleeding top talent, and investors are concerned the electric carmaker can't possibly be profitable by the second half of 2018 as its chief executive Elon Musk predicted. Musk sent a [memo to employees](https://www.wsj.com/articles/tesla-ceo-musk-says-company-is-flattening-management-structure-inreorganization-1526308678) Monday saying he was "flattening" the electric carmaker's management structure as part of a company-wide reorganization. The reorganization comes after Tesla announced that its engineering chief would take a leave of absence and another senior executive left for Waymo, a competitor in the race to develop self-piloted vehicles. "It definitely has an effect and I think you can correctly assume that these people had a lot to do with the company's day-to-day," said Aaron Cole, the managing editor at Motor Authority. "What this means going forward, we're not entirely sure." An analyst at Morgan Stanley recently [cut the company's target price] (https://www.barrons.com/articles/tesla-ford-could-be-stalled-1526395206) from $376 to $291, signaling a loss of faith in the stock as Tesla struggles to hit production targets for its Model 3 vehicle ー the linchpin in Musk's strategy. "There's only so many hours in the day and Musk has said that he's sleeping in the office and that he's doing everything that he can but there's only so much that one person can do," said Cole. For the full interview, [click here](https://cheddar.com/videos/tesla-restructures-as-company-bleeds-talent).

Share:
More In Business
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More